BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38683294)

  • 1. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):371-394. PubMed ID: 34713480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta-analysis.
    Melin JM; Forslund M; Alesi SJ; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena AS; Witchel SF; Mousa A; Teede HJ
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):149-163. PubMed ID: 37933831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
    Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
    Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: A systematic review and meta-analysis.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):443-459. PubMed ID: 34779013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
    Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
    Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
    Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.
    Sheth SH; Larson RJ
    BMC Infect Dis; 2010 Jun; 10():183. PubMed ID: 20573187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
    Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
    J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and glitazones: do they really help PCOS patients?
    Pillai A; Bang H; Green C
    J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.